申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20160159769A1
公开(公告)日:2016-06-09
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
本文提供了I式化合物,包括药用可接受的盐,以及使用该化合物的组合物和方法。该化合物对丙型肝炎病毒(HCV)具有活性,可能有助于治疗感染HCV的患者。